Sign in
Enrolling by invitationPhase 4

Suzetrigine versus oxycodone for pain after knee replacement surgery

Compares suzetrigine with oxycodone for pain after knee replacement in people with knee osteoarthritis.

Key facts

Who runs it
University of Louisville
Where
Louisville, United StatesSee the site
Trial code
Registry title
Comparison of Suzetrigine and Oxycodone for Postoperative Pain After Primary Total Knee Arthroplasty
Status
Enrolling by invitation
Phase
Phase 4
People taking part
140 people, planned
Started
9 Feb 2026
Expected to end
30 Apr 2027
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • oral suzetrigine
  • oral Oxycodone
Record updated
4 May 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with knee osteoarthritis who are scheduled for a first total knee replacement on one knee. It compares suzetrigine with Oxycodone for pain after surgery.

Age
21 to 89 years at the time of surgery
Sex
All sexes
Disease stage
Osteoarthritis of the knee, with a planned first (primary) total knee replacement on one side only
Earlier treatment
People cannot join if they took opioids in the 90 days before enrolment.

Main reasons for not taking part

  • Main diagnosis is not osteoarthritis
  • Unable to read and speak English
  • Allergy to suzetrigine or a reason it cannot be used
  • Pregnant or breastfeeding
  • Opioid use in the 90 days before enrolment

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Patient age is 21-89 at time of surgery
  • Patient is scheduled to undergo a unilateral primary TKA, secondary to osteoarthritis
  • Patient agrees to participate as a study subject and signs the Informed Consent and Research Authorization document
  • Patient is able to read and speak English

Who cannot take part

  • Patient has taken opioids within the 90 days prior to enrollment
  • Contraindication or Hypersensitivity to suzetrigine
  • Patient is under the age of 21
  • Patient's primary diagnosis is not osteoarthritis
  • Patient is unable to read and speak English
  • Pregnant or nursing females

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 21 and 89 years old?

Where in United States

  • UofL HealthLouisville, United StatesEnrolling by invitation

About the trial

What the trial wants to find out

The purpose this study is determine whether postoperative oral dosage of suzetrigine is effective at controlling postoperative pain and reducing analgesic requirements following primary total knee arthroplasty (TKA) versus a control group of TKA patients receiving postoperative Oxycodone.

The 2 groups in the trial

  • Group A: suzetrigine groupTreatment being tested

    Participant will receive a two-week supply of oral suzetrigine upon discharge. Participant will also receive a 10-pill supply of Oxycodone as a rescue medication.

    Treatment: oral suzetrigine

  • Group B: Oxycodone groupExisting treatment, for comparison

    Participant will receive a two-week supply of oral Oxycodone upon discharge

    Treatment: oral Oxycodone

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Comparison of Suzetrigine and Oxycodone for Postoperative Pain and Analgesic Requirements After Primary Total Knee Arthroplasty: a Prospective, Randomized Study
Plain-language title
Suzetrigine versus oxycodone for pain after knee replacement surgeryGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Fit questions
Built from NCT07219888, who can take part
Record updated
4 May 2026